Cigniti Technologies

Cigniti Technologies is now a Coforge company, operating as a global provider of digital assurance and quality engineering services. With over 4,200 employees worldwide, the firm serves 60+ Fortune 500 companies across multiple industries including healthcare and life sciences, financial services, retail, telecom, and utilities.

The company specializes in AI-powered testing and quality assurance, leveraging proprietary platforms like BlueSwan for next-generation digital assurance with predictive capabilities. Their approach combines test automation, security testing, and specialized domain expertise to accelerate digital transformation initiatives. Cigniti has delivered over 1 million automation scripts and assured more than 10,000 applications, reportedly saving clients over $500 million in costs.

In healthcare specifically, Cigniti focuses on medical device testing and validation, including FDA cybersecurity compliance and connected device quality engineering. The company achieved recognition as a Disruptor in HFS Research's 2024 Horizons report for Assuring the Generative Enterprise Services, highlighting their AI-driven competencies in software quality assurance.

Organizations should consider Cigniti when they need enterprise-grade quality assurance capabilities combined with healthcare domain knowledge, particularly for medical device testing and validation. The firm excels in scenarios requiring AI-powered test automation at scale and navigating complex regulatory requirements like FDA cybersecurity mandates.

Expect a structured engagement model leveraging proprietary platforms and methodologies, with access to global delivery teams. The Coforge acquisition potentially provides broader digital transformation capabilities beyond pure testing services, suitable for organizations seeking comprehensive technology partnerships.

Cigniti's healthcare practice concentrates on medical device testing and quality engineering, with particular emphasis on FDA cybersecurity compliance mandates. The firm has documented experience with connected medical device manufacturers, delivering 50% faster testing cycles through specialized design verification expertise.

Their healthcare capabilities extend to healthcare and life sciences clients beyond medical devices, though medical device testing appears to be their primary healthcare vertical. The company addresses regulatory testing requirements, connected device validation, and quality assurance for healthcare technology applications.

The ideal client is a mid-to-large medical device manufacturer or healthcare enterprise pursuing digital transformation with complex testing requirements. They value AI-powered automation, require FDA regulatory compliance expertise, and benefit from a partner with global delivery capabilities and proven Fortune 500 experience across multiple technology domains.